慢性肾脏病中新发房颤的预测:慢性肾功能不全队列研究
在2766例无房颤史的CKD患者中,比较CHARGE-AF模型与机器学习模型预测新发房颤。中位随访8年发生259例事件,各模型C指数均为0.67左右,加入NT-proBNP和高敏肌钙蛋白T后最终模型区分度中等。
要点
- CHARGE-AF模型在CKD人群中C指数为0.67,区分度中等。
- 机器学习模型仅用临床变量C指数也为0.67,加入NT-proBNP或联合肌钙蛋白T提高0.04。
- 最终模型含12项临床变量及NT-proBNP、高敏肌钙蛋白T,区分度中等。
核心结论
- 包含12项标准临床变量和心脏生物标志物NT-proBNP及高敏肌钙蛋白T的机器学习模型,在CKD人群中对新发房颤具有中等区分度。
研究设计与样本
- 慢性肾功能不全队列研究(CRIC)中2766例无既往房颤且心脏生物标志物和临床数据完整的参与者。
- 比较CHARGE-AF预测模型(含11个预测因子,使用原始和重新估计系数)与机器学习方法预测新发房颤。
- 采用十折交叉验证C指数评估区分度,图形法和Grønnesby and Borgan检验评估校准。
主要发现
- 参与者平均(SD)年龄57(11)岁,55%为男性,38%为黑人,平均(SD)eGFR为45(15) ml/min per 1.73 m2。
- 中位随访8年期间发生259例新发房颤事件。
- CHARGE-AF预测方程使用原始和重新估计系数的C指数分别为0.67(95%CI 0.64-0.71)和0.67(95%CI 0.64-0.70)。
- 仅用临床变量的似然提升模型C指数为0.67(95%CI 0.64-0.70);加入NT-proBNP、高敏肌钙蛋白T或两者分别提高C指数0.04、0.01和0.04。
- 最终模型除NT-proBNP和高敏肌钙蛋白T外,还包括年龄、非西班牙裔黑人种族/族裔、西班牙裔种族/族裔、心血管疾病、慢性阻塞性肺疾病、心肌梗死、外周血管疾病、ACEI/ARB使用、钙通道阻滞剂、利尿剂、身高和体重。
关键数值与推荐
- CHARGE-AF模型含11个预测因子。
- 最终机器学习模型含12项标准临床变量及NT-proBNP和高敏肌钙蛋白T。
- 各模型C指数均为0.67左右,加入生物标志物后提高0.01至0.04。
临床怎么用
- 在CKD患者中可使用含临床变量和心脏生物标志物的模型评估新发房颤风险,但区分度中等,需结合临床判断。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Atrial fibrillation (AF) is common in CKD and associated with poor kidney and cardiovascular outcomes. Prediction models developed using novel methods may be useful to identify patients with CKD at highest risk of incident AF. We compared a previously published prediction model with models developed using machine learning methods in a CKD population. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We studied 2766 participants in the Chronic Renal Insufficiency Cohort study without prior AF with complete cardiac biomarker (N-terminal pro-B-type natriuretic peptide and high-sensitivity troponin T) and clinical data. We evaluated the utility of machine learning methods as well as a previously validated clinical prediction model (Cohorts for Heart and Aging Research in Genomic Epidemiology [CHARGE]-AF, which included 11 predictors, using original and re-estimated coefficients) to predict incident AF. Discriminatory ability of each model was assessed using the ten-fold cross-validated C-index; calibration was evaluated graphically and with the Grønnesby and Borgan test. RESULTS: Mean (SD) age of participants was 57 (11) years, 55% were men, 38% were Black, and mean (SD) eGFR was 45 (15) ml/min per 1.73 m2; 259 incident AF events occurred during a median of 8 years of follow-up. The CHARGE-AF prediction equation using original and re-estimated coefficients had C-indices of 0.67 (95% confidence interval, 0.64 to 0.71) and 0.67 (95% confidence interval, 0.64 to 0.70), respectively. A likelihood-based boosting model using clinical variables only had a C-index of 0.67 (95% confidence interval, 0.64 to 0.70); adding N-terminal pro-B-type natriuretic peptide, high-sensitivity troponin T, or both biomarkers improved the C-index by 0.04, 0.01, and 0.04, respectively. In addition to N-terminal pro-B-type natriuretic peptide and high-sensitivity troponin T, the final model included age, non-Hispanic Black race/ethnicity, Hispanic race/ethnicity, cardiovascular disease, chronic obstructive pulmonary disease, myocardial infarction, peripheral vascular disease, use of angiotensin-converting enzyme inhibitor/angiotensin receptor blockers, calcium channel blockers, diuretics, height, and weight. CONCLUSIONS: Using machine learning algorithms, a model that included 12 standard clinical variables and cardiac-specific biomarkers N-terminal pro-B-type natriuretic peptide and high-sensitivity troponin T had moderate discrimination for incident AF in a CKD population.
引用
- Zelnick LR, Shlipak MG, Soliman EZ, et al. Prediction of Incident Atrial Fibrillation in Chronic Kidney Disease: The Chronic Renal Insufficiency Cohort Study. Clin J Am Soc Nephrol. 2021. PMID: 34597264. doi:10.2215/CJN.01060121
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。